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In Brief Lian et al. show that the neuroinflammatory regulator NFkB modulates neuronal morphology and function through complement C3 activation in astroglia. Rescue of cognitive deficits in an Alzheimer's disease mouse model by C3a receptor blockade implicates its potential for AD therapy.
INTRODUCTION
Astroglia are responsible for diverse functions in the CNS and play a crucial role in maintaining neuronal physiology. Astroglia maintain glucose, ATP, and glutamate homeostasis; modulate synaptic formation and function; and are an essential component of the blood-brain barrier (Coulter and Eid, 2012; Lalo et al., 2014; Seifert and Steinhä user, 2013) . In response to brain insults such as injury, infection, or neurodegeneration, astroglia become reactive, which results in the activation of immune mediators and release of proinflammatory cytokines (reviewed by Kyritsis et al., 2014) . A key regulator of inflammation in the peripheral system and CNS is the heterodimeric transcription factor nuclear factor kB (NFkB) (reviewed by Baltimore, 2011; Oeckinghaus and Ghosh, 2009) . Under normal conditions, NFkB is tightly regulated by its inhibitor protein IkB, which sequesters NFkB in the cytoplasm. Upon degradation of IkB, NFkB translocates to the nucleus where it activates expression of kB target genes, including its inhibitor IkBa (Chiao et al., 1994) , which form an autoinhibitory feedback loop that ensures proper silencing of NFkB following each activation. Accordingly, deletion of IkBa (Beg et al., 1995; Klement et al., 1996) or disruption of the kB sites in the IkBa promoter (Peng et al., 2010; Shim et al., 2011) leads to aberrant NFkB activation and a spectrum of immunological phenotypes.
Activation of NFkB is associated with various neurodegenerative conditions, including Alzheimer's disease (Kaltschmidt et al., 1997; Mori et al., 2010 ), Parkinson's disease (Hunot et al., 1997) , and Huntington's disease (Hsiao et al., 2013) . Both neurotoxic and neuroprotective roles have been proposed for NFkB, with the outcome likely dependent on the timing, duration, and level of activity (reviewed by Mattson et al., 2000; Mattson and Meffert, 2006; Pizzi and Spano, 2006) . Given the potential importance of aberrant NFkB activation in neuroinflammatory conditions, it is important to clarify the signaling cascades mediating its activity in neurons and glia and to understand the conditions under which NFkB either attenuates or aggravates disease.
The complement pathway is an essential immune regulator of host defense to infection, cell integrity, and tissue homeostasis in the peripheral system (Holers, 2014; Ricklin and Lambris, 2013) . Full complement activation involves concerted actions of over 30 proteins that participate in three distinct pathways: classical, alternative, and mannose-binding-lection. All converge on the cleavage of the central complement protein C3 (Zipfel and Skerka, 2009 ). In the CNS, complement factors such as C3a and C1q have been shown to regulate synaptic refinement and neuronal survival during development (Benoit and Tenner, 2011; Shinjyo et al., 2009; Stevens et al., 2007) . However, little is known about the mechanisms regulating complement expression and its influence on neuronal function and dysfunction in the adult brain.
Here we examined the cell-specific effects of NFkB activation in neurons and astroglia by deleting its inhibitor, IkBa, in these cell types. We identify a novel neuron-glia interaction pathway whereby astroglial NFkB activation and subsequent release of complement C3 acts through the neuronal C3a receptor to impair dendritic structure and network function.
RESULTS

Complement Factor C3 Is an Astroglial Target of NFkB
We created a CNS-specific IkBa deletion (NcKO) by crossing an IkBa floxed allele with a Nestin-Cre transgenic line (Lian et al., 2012) . Consistent with its role as a principal inhibitor of NFkB, we found that deletion of IkBa was associated with sustained NFkB activity (Lian et al., 2012) . We performed expression profiling of hippocampal samples taken from the NcKO mice and their littermate controls to identify downstream targets activated by NFkB ( Figure S1A available online). Among the many genes identified, we found that complement factor 3 (C3), a central molecule in the complement signaling pathway, was significantly upregulated in the NcKO mice ( Figure S1A ; Figure 1A ).
We and others have shown previously that astrocytes display prominent NFkB activity (Herkenham et al., 2011; Lian et al., 2012; Mao et al., 2009) . Consistent with an astrocytic bias in NFkB signaling, we found that IkBa, a known downstream target of NFkB, was expressed at substantially higher levels in astroglia than in neurons under both basal ($5-fold) and tumor necrosis factor a (TNF-a)-stimulated conditions ($50-fold) ( Figure S1B ). TNF-a induced drastic IkBa upregulation in astroglia but only marginal induction in neurons ( Figure S1B ). These results establish that astroglia, rather than neurons, are the main site of IkBa expression and NFkB activity.
The prominent NFkB response in astroglia suggests that the rise in hippocampal C3 expression observed in the NcKO mice likely originated from astroglia. To test this prediction, we crossed the IkBa floxed allele with CaMKIIa-Cre (Dragatsis and Zeitlin, 2000) or GFAP-Cre (Bajenaru et al., 2002) to create mice with selective IkBa deletion in neurons (CcKO) or in astrocytes (GcKO), respectively ( Figure S1C ). Astroglial deletion of IkBa reduced the level of IkBa mRNA and protein by roughly the same amount as the whole-brain knockout, confirming that the majority of NFkB signaling was indeed localized to astrocytes (Figures S1D and S1E). C3 mRNA expression in the astrocytespecific GcKO, but not in the neuron-specific CcKO, also matched that of whole-brain NcKO ( Figure 1A ). ELISA analysis confirmed elevation of C3 protein levels in the GcKO mice (Figure 1B) . As with whole-brain IkBa deletion, no overt phenotypes were detected in the GcKO mice ( Figure S1F ).
The C3 promoter contains two putative kB binding sites (Figure S1G) and is speculated to be an NFkB target (Moon et al., 1999; Vik et al., 1991) . To test whether C3 transcription is mediated by direct binding of NFkB to the C3 promoter, we performed chromatin immunoprecipitation in primary astroglial cultures using an anti-p65 antibody to recover DNA bound to NFkB in the presence and absence of TNF-a stimulation. PCR analysis showed that although the kB-1 site was enriched in all immunoprecipitates, the kB-2 site was enriched only upon TNF-a stimulation (Figures S1G and S1H) . Although the reason for the differential response to TNF-a remains to be established, this result validated C3 as a direct NFkB target in astroglia.
The GFAP-Cre line can evoke neuronal deletion of floxed alleles (Bajenaru et al., 2002; Drö gemü ller et al., 2008) , so we employed a second strategy to confirm that astrocytes were selectively responsible for C3 elevation following NFkB activation. We prepared primary astroglial and neuronal cultures derived from germline IkBa knockout mice (KO) and their littermate wild-type (WT) controls (Beg et al., 1995) . In agreement with the in vivo data, we detected $10-fold higher basal C3 mRNA levels in WT astroglial cultures compared with the WT neuronal cultures (compare WT Astroglia with WT Neuron, Figure S1 . Figure 1C ). Significantly, IkBa deletion did not affect C3 expression in neuronal cultures (compare KO Neuron with WT Neuron, Figure 1C ) but led to an approximately 3-fold further increase in astroglia (compare KO Astroglia with WT Astroglia, Figure 1C ). Increased astroglial C3 in the absence of IkBa was further confirmed by normalizing C3 mRNA with other housekeeping genes (Figures S1I and S1J) and by measuring secreted C3 protein in conditioned media of WT and IkBa KO astroglial cultures ( Figure 1D ). To confirm that C3 overexpression in IkBa mutants is dependent on NFkB, we applied the NFkB inhibitor JSH23 to WT and IkBa KO primary astroglial cultures in the presence or absence of TNF-a. We found that C3 mRNA levels were not affected by JSH23 in WT cultures but that both basal and TNF-a-induced C3 upregulation was potently blunted by JSH23 in IkBa KO astrocytes ( Figure 1E ). We noticed a small but significant increase of C3 in WT cultures in response to TNF-a stimulation ( Figure 1E , WT, À versus + TNF-a). However, this pool was insensitive to JSH23, suggesting that other transcriptional modulators, such as C/EBP or mitogen-activated protein kinase, were responsible for the increase (Maranto et al., 2008 (Maranto et al., , 2011 . Taken together, our in vivo and in vitro data provide unequivocal support for the hypothesis that astroglia, rather than neurons, are the principle site of NFkB activation and primarily responsible for the NFkBdependent increase in C3.
Given that C3 is a central molecule in the complement signaling cascade, we tested which complement pathway is activated by C3 overexpression. We measured the mRNA of proteins required for classical (C1q and C4) or alternative (Cfb and Cfh) complement pathways in WT and IkBa-deficient astroglial cultures ( Figure S1K ) and mouse brains ( Figure S1L ). We detected upregulation of classical complement factors C1q and C4 but not the alternative pathway factors Cfb or Cfh. These results suggest that astroglial NFkB/C3 promotes activation of the classical complement pathway.
Astroglial NFkB/C3 Activation Leads to Impaired Synaptic Density and Dendritic Morphology We next wanted to explore what impact astrocytic C3 release might have on the structure or function of neighboring neurons. We employed a coculture system of primary WT or IkBa knockout astroglia (WTAs or KOAs, respectively) with WT hippocampal neurons to measure synaptic density and dendritic morphology in the presence or absence of astroglial NFkB activation. Double immunostaining of these cultures with NeuN/Iba1 ( Figure S2A ) or GFAP/Iba1 ( Figure S2B ) revealed that microglia comprise less than 1% of the total cell population in both neuronal and astrocytic cultures ( Figure S2C ), arguing against a potential contribution of microglia in the culture system. Synaptic density was evaluated by coimmunostaining for the synaptic marker synaptophysin (Syn) and the dendritic microtubule-associated protein 2 (MAP2) (Figure 2A ). We found a significant reduction of synaptic density in WT neurons cocultured with IkBa KO astroglia ( Figure 2C ). Further examination of excitatory and inhibitory synapses using vesicular glutamate transporter 1 (VGluT1, Figure 2B ) or vesicular g-aminobutyric acid transporter (VGAT, Figure S2D ), respectively, revealed a significant reduction in excitatory but not inhibitory synapses (Figure 2C ). In addition, both total dendritic length ( Figure 2D ) and dendritic complexity (Figures 2E and 2F) were reduced in neurons plated with IkBa KO astrocytes.
To test that the neuronal phenotypes triggered by IkBa KO astroglia were mediated through C3, we supplemented WT neuronal monocultures with different doses (1, 2, and 5 mg/ml) of recombinant C3 and determined the effect on neuronal morphology. Similar to neurons cultured with KO astrocytes, both the synaptic density ( Figures 2G and 2H ) and dendritic complexity (Figures 2I and 2J) were reduced at all C3 concentrations tested. Conversely, we tested whether immunodepletion of C3 from conditioned medium derived from IkBa KO astroglia would abrogate its impact on neuronal morphology. Neurons treated with C3-depleted but not GFP-depleted medium maintained normal dendritic morphology (Figures S2H and S2I) . These experiments support a role for secreted C3 in mediating the effects of astroglial NFkB activation on neuronal morphology.
To corroborate these findings in vivo, we used adeno-associated virus (AAV) to sparsely label cortical neurons with GFP in adult WT and astroglial IkBa-deficient (GcKO) mice ( Figure 3 ; Movie S1). We reconstructed the 3D structure of dendritic segments to perform an unbiased automatic classification of spine types (mushroom, stubby, long-thin, and filopodia) ( Figure 3A ). With the exception of filopodia, all other spine types ( Figure 3C ; Figure S3B ) as well as total spine density ( Figure 3B ; Figure S3A ) were significantly reduced in the GcKO mice without altering the relative percentage of each spine type ( Figure 3D ; Figure S3C ).
Neuronal Complement Receptor C3aR Mediates the Effect of Astroglial NFkB/C3 Signaling
We next wanted to test whether the neuronal complement receptor was required to translate astrocytic C3 release into a neuronal morphological response. Cleavage of C3 generates C3a and C5a, which executes complement functions through binding of its receptors C3aR and C5aR, respectively (Nataf et al., 1999; Rahpeymai et al., 2006) . C3aR and C5aR are both G protein-coupled receptors expressed in many cell types, including neurons (Bé nard et al., 2008; Gasque et al., 2000; Shinjyo et al., 2009 ). We tested whether C3aR or C5aR were neuronal mediators of the NFkB/complement pathway by treating neuronastrocyte cocultures with antagonists against C3aR (C3aRA) or C5aR (C5aRA). We again used WT neurons cultured with either WT or IkBa KO astrocytes in the presence or absence of these complement receptor antagonists. Sholl analysis revealed that blocking C3aR, but not C5aR, preserved dendritic branching and spine density in the KOA cultures (Figures 4A and 4B; . Although the C3aR antagonist increased dendritic complexity in neurons cultured with KO astrocytes (Figure 4B , KOA, DMSO versus C3aRA), it had an apparent opposite effect on neurons cultured with WT astrocytes ( Figure 4B , WTA, DMSO versus C3aRA). These results suggest that although excessive C3/C3aR activity is detrimental to neuronal health, basal C3aR signaling might play a role in maintaining normal dendritic extension.
C3aR is expressed in both neurons and astroglia, and, therefore, it is plausible that astroglial C3aR may have contributed to the effects of C3aR manipulation in our coculture system. To rule out this possibility, we tested whether loss of neuronal 
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An NFkB/C3/C3aR Neuron-Glia Signaling Pathway C3aR would abrogate dendritic phenotypes when cultured with IkBa KO astrocytes. We again performed coculture experiments with IkBa KO astrocytes but used neurons derived from WT (C3aRWTN) or C3aR-null (C3aRKON) mice (Humbles et al., 2000; Figures 4C and 4D) . We found that dendritic complexity in neurons cultured with IkBa KO astrocytes was preserved by neuronal C3aR deletion ( Figure 4D ), therefore establishing a definitive role of neuronal C3aR in the response to astroglial C3 release. Unlike with C3aRA treatment, although there is a trend of reduction in dendritic extension in C3aR knockout neurons, the difference did not reach statistical significance (compare C3aRWTN WTAs with C3aRKON WTAs, Figure 4D ). Possible compensation resulting from germline C3aR deficiency may be a contributing factor for the differences between pharmacological inactivation and genetic ablation.
To provide in vivo evidence that C3aR is required for the observed effects of astroglial NFkB activation, we treated WT (F) Quantification of dendritic complexity of WTA and KOA cocultured neurons by Sholl analysis. n WTA = 39 and n KOA = 44 (two-way ANOVA). (G) Double-staining of Syn and MAP2 of WT neurons treated with vehicle (PBS) or 5 mg/ml C3. Scale bar, 10 mm. (H) Quantified synaptic density of neurons treated with PBS or C3 at 1, 2, or 5 mg/ml. n PBS = 36, n 1 mg/ml = 33, n 2 mg/ml = 37, and n 5 mg/ml = 29 (one-way ANOVA followed by Bonferroni post hoc analysis). (I) Representative dendritic structures of WT neurons treated with PBS or 5 mg/ml C3. Scale bar, 20 mm. (J) Dendritic complexity quantification of WT neurons treated with PBS or C3 at 1, 2, and 5 mg/ml. n PBS = 116, n 1 mg/ml = 66, n 2 mg/ml = 53, and n 5 mg/ml = 68 (two-way ANOVA followed by Bonferroni post-hoc analysis). *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S2 . 
. Impaired Dendritic Morphology in GcKO Mice
(A) Schematic of the steps taken for dendritic spine analysis in vivo. Four-month-old littermate control (Ctrl) and GcKO mouse brains were stereotaxically injected with AAV-GFP virus followed by measurement of spine density 3 weeks later. IMARIS was used to reconstruct the 3D renderings of the spines on dendrites based on confocal images of GFP-positive neurons and to classify the four spine types (mushroom, stubby, long-thin, and filopodia). Scale bar, 5 mm. (B) Total spine density in Ctrl and GcKO mouse brains. n Ctrl = 25 and n GcKO = 22. (C) Density of each of the four spine types in Ctrl and GcKO mouse brains. n Ctrl = 39 and n GcKO = 31. (D) Frequency of each spine type. Dendritic segments were derived from 3 animals/ group, Student's t test. *p < 0.05; **p < 0.01; ***p < 0.001. See also Movie S1 and Figure S3 .
and GcKO mice systemically with C3aR antagonist (Figures 4E and 4F) . AAV was again used to sparsely label cortical neurons with GFP so spine density could be measured following 3 weeks of antagonist or vehicle treatment. Although C3aRA treatment had no significant effect on WT animals ( Figure 4F ; Figure S4F , Ctrl, DMSO versus C3RA), it completely rescued spine density in GcKO mice (Figure 4F ; Figure S4F , GcKO, DMSO versus C3aRA). Taken together, these results demonstrate that abnormal C3/C3aR signaling affects neuronal morphology in vitro and in vivo.
The above studies identified a novel pathway by which astroglial NFkB activation leads to elevated complement signaling and reduced synaptic and dendritic densities in vitro and in vivo. These were correlated with neuronal circuitry deficits because the IkBa GcKO mice exhibited an impaired hippocampal-dependent contextual fear response ( Figure 4G ) and long-term potentiation (LTP) of the Schaffer collateral pathway ( Figure 4I ). Consistent with the rescue of dendritic morphology by C3aR blockade, both the behavioral and synaptic plasticity deficits were attenuated by C3aR antagonist treatment ( Figures 4H and 4J ).
Intraneuronal Calcium Mediates Neuronal Excitation Downstream of C3aR
It has been reported that C3aR hyperactivation can mobilize intracellular calcium in some cell types (Ahamed et al., 2004;  Neuron An NFkB/C3/C3aR Neuron-Glia Signaling Pathway (D) Sholl analysis of the dendritic complexity of WTA or KOA cocultured C3aRWTN or C3aRKON neurons. n C3aRWTN WTA = 46, n C3aRKOA WTA = 51, n C3aRWTN KOA = 44, and n C3aRKOA KOA = 46 (three-way ANOVA followed by pairwise comparison). (E) Representative dendritic spines in 10-month-old Ctrl or GcKO mouse brains treated with DMSO or C3aRA (1 mg/kg i.p.) for 3 weeks. Scale bar, 10 mm. (F) Quantification of spine density in Ctrl or GcKO mouse brains treated with DMSO or C3aRA. n Ctrl DMSO = 69, n GcKO DMSO = 80, n Ctrl C3aRA = 41, and n GcKO C3aRA = 43. Dendritic segments from 3 animals/group were selected for spine density quantification (two-way ANOVA followed by pairwise comparison). (G) Reduced contextual freezing in GcKO mice. n Ctrl = 14 and n GcKO = 18 (Student's t test). (H) Rescue of contextual memory defects of GcKO mice by C3aRA treatment. DMSO, vehicle treated controls. n Ctrl DMSO = 6, n GcKO DMSO = 7, n Ctrl C3aRA = 8, and n GcKO C3aRA = 6 (two-way ANOVA followed by pairwise comparison). (I) Slope of fEPSP in response to q burst stimulation delivered to the Schaffer collateral pathway from Ctrl or GcKO mice treated with DMSO or C3aRA. (J) Quantification of the average fEPSP slope in the last 10 min. n Ctrl DMSO = 6, n GcKO DMSO = 5, n Ctrl C3aRA = 8, and n GcKO C3aRA = 6 (two-way ANOVA followed by pairwise comparison). *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S4 . Murakami et al., 1993; Sayah et al., 2003) . Calcium dysregulation could, in turn, initiate a cascade of changes, ultimately leading to alteration of neuronal morphology and function. We examined intraneuronal calcium flux in both astrocyte-neuron cocultures and brain slice cultures with the fluorescent reporter GCaMP6 . WT neurons cultured with IkBa KOAs showed substantially higher baseline calcium levels than neurons cultured with WT astrocytes (Figures 5A and 5B). We observed a similar elevation in baseline calcium of GcKO slice cultures compared with littermate controls ( Figures  5C and 5D ). Baseline calcium levels were restored to normal both by application of the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid-acetoxymethyl ester (BAPTA/AM) or C3aRA to the cultured slices, suggesting that calcium dysregulation was downstream of C3aR signaling (Figure 5E ). Finally, normalizing calcium levels with BAPTA/AM (Figure 5E ) rescued dendritic morphology in neurons cultured with IkBa KO astrocytes ( Figures 5F and 5G) , placing intraneuronal calcium in the pathway leading from activated NFkB to altered neuronal morphology.
The above studies established a novel function of astroglial NFkB, through C3/C3aR signaling and intraneuronal calcium regulation, in mediating excitatory synaptic density and dendritic morphology. We next performed electrophysiological recordings of excitatory synaptic transmission in neurons cocultured with WT or IkBa KO astrocytes. We observed miniature excitatory postsynaptic currents (EPSCs) of larger amplitude in neurons cultured with IkBa KO astrocytes than with WT astrocytes, despite no change in frequency, indicating that synaptic strength was increased by astroglial NFkB/C3 signaling ( Figures 6A-6D ). The strength of postsynaptic events is controlled predominantly by á -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor (AMPAR) trafficking (Derkach et al., 2007; Song and Huganir, 2002; Yamada, 1998) , so we performed immunocytochemical staining of the AMPAR subunit GluR1 to examine its surface expression ( Figure 6E ). Compared with the (E) Mean GCaMP fluorescence of Ctrl and GcKO slice cultures treated with DMSO, 10 mM C3aRA, or 50 mM BAPTA/AM. n Ctrl DMSO = 103, n GcKO DMSO = 104, n Ctrl BAPTA/AM = 60, n GcKO BAPTA/AM = 60, n Ctrl C3aRA = 180, and n GcKO C3aRA = 104 (two-way ANOVA followed by Bonferroni post-hoc analysis). (F) Representative images of MAP2-positive dendritic morphologies in WTA or KOA cocultured neurons treated with DMSO or 1 mM BAPTA/AM for 4 days. Scale bar, 50 mm. (G) Sholl analysis of dendritic complexity of WTA or KOA cocultured neurons treated with DMSO or BAPTA/AM. n WTA DMSO = 52, n KOA DMSO = 62, and n KOA BAPTA/AM = 70 (three-way ANOVA followed by pairwise comparison). *p < 0.05; **p < 0.01; ***p < 0.001. See also Movie S2. 
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An NFkB/C3/C3aR Neuron-Glia Signaling Pathway WT cocultures, neurons cultured with IkBa KO astrocytes displayed higher surface GluR1 intensity both generally at the cell membrane ( Figure 6F ) and specifically within synaptophysinpositive (Syn + ) puncta ( Figure 6G ). In contrast, total GluR1 intensity was not changed, both when measured by immunostaining of cocultured neurons ( Figures S5A and S5B ) and by western blot using lysates from cocultured neurons or GcKO brains (Figures S5C-S5F ). Increased surface GluR1 was further validated by western blotting of biotinylated cell surface GluR1, which showed a significant upregulation in neurons cultured with IkBa KO astrocytes ( Figures 6H and 6I ). These data suggest that astroglial NFkB activation results in significant enrichment of AMPAR at the postsynaptic surface.
Consistent with the prominent rescue of spine density in vitro and in vivo by C3aR inhibition, application of C3aRA to WT neurons cultured with IkBa KO astrocytes normalized miniature EPSC (mEPSC) amplitude ( Figures 6J and 6K ) as well as surface AMPAR expression ( Figures 6L and 6M ). Diminished levels of surface AMPAR were observed within 15 min of C3aRA treatment ( Figure S5G ), strongly supporting a direct effect of C3/ C3aR signaling. Similar to C3aRA, treatment with BAPTA/AM also rescued surface GluR1 expression in neurons cultured with KO astrocytes (Figure 6N ), supporting the idea that intraneuronal calcium mediates AMPAR trafficking downstream of astroglial NFkB/C3.
Alterations of NFkB and C3 Levels by Ab and in AD Brains
Substantial evidence has implicated dysregulation of NFkB and calcium homeostasis in Alzheimer's disease (AD) pathogenesis (LaFerla, 2002; Mattson, 2007; Mattson and Meffert, 2006) . To explore whether the astroglial NFkB/C3 pathway uncovered here is induced under conditions relevant to AD, we treated WT primary astroglial cultures with either the Ab42 peptide or the control reverse peptide rAb42. Remarkably, treatment with Ab42, but not rAb42, resulted in prominent translocation of NFkB from the cytoplasm to the nucleus ( Figures 7A and 7B ) and increased expression of C3 mRNA ( Figure 7C ).
We next examined whether Ab accumulation in vivo was associated with C3 elevation and whether inhibiting C3aR signaling could rescue cognitive impairment in amyloid-bearing mice. Consistent with the effect of Ab in vitro, we found that C3 mRNA levels were significantly higher in APP/TTA double transgenic mice than in TTA single-transgenic controls ( Figure 7D ; Jankowsky et al., 2005) . We then treated mice with C3aRA or vehicle (DMSO) for 3 weeks before testing their performance in a Morris water maze (MWM) and radial arm water maze (RAWM) (Fowler et al., 2014) . Treatment was initiated at an age when cognitive impairments are already manifested, and, consistent with past characterization of this model, vehicletreated APP/TTA mice took more days of training than TTA controls to reach criterion performance in the MWM and made more working memory errors in the RAWM (Figures 7E and  7F) . Although C3aRA treatment did not change the behavior of control TTA mice, it improved the performance of APP/TTA mice to control levels in both tasks ( Figures 7E and 7F) .
To further assess whether this pathway is perturbed in human disease, we performed a biochemical analysis of NFkB, IkBa, and C3 in postmortem AD brains and age-matched nondemented controls. Both NFkB, measured by nuclear p65 levels ( Figure 7G ), and its targets IkBa ( Figures 7H and 7I ) and C3 (Figure 7J) were significantly higher in AD samples than in controls. Although the sequence of events leading to upregulation of NFkB signaling in AD remains to be elucidated, our findings overall support a role for altered astrocytic IkBa/NFkB signaling in AD pathophysiology.
DISCUSSION
Loss-of-function studies have revealed essential roles of NFkB and the complement system in neuronal function and synapse elimination during development (Boersma et al., 2011; Koo et al., 2010; Meffert et al., 2003; Stevens et al., 2007) , However, these pathways are known to be activated under pathological conditions. Very few genetic gain-of-function models have been generated (Gerondakis et al., 2006; Hanafusa et al., 2002) , and those that exist have been limited to ectopic overexpression, which may not be appropriate for understanding these pathways in pathological conditions. Furthermore, little is known about cell type-specific regulation and crosstalk between the two pathways. Here we used Cre-directed IkBa deletion to create mice in which NFkB was selectively activated in either neurons or astroglia and combined the genetic model with neuron-astrocyte cocultures to study the consequence of aberrant NFkB signaling in the brain. We reveal that (1) astroglia, not neurons, are the main source of IkBa-dependent NFkB activation; (2) complement factor C3 is an astroglial NFkB target that engages neuron-glia interaction through neuronal C3aR; (3) aberrant elevation of NFkB/C3/C3aR signaling alters dendritic (E) Rescue of Morris water maze deficits in APP/TTA mice by C3aRA (n TTA DMSO = 7, n APP/TTA DMSO = 8, n TTA C3aRA = 6, and n APP/TTA C3aRA = 7; two-way ANOVA followed by pairwise comparison).
(F) Rescue of radial arm water maze deficits in APP/TTA mice by C3aRA (n TTA DMSO = 7, n APP/TTA DMSO = 8, n TTA C3aRA = 5, and n APP/TTA C3aRA = 7; two-way ANOVA followed by pairwise comparison).
(G) ELISA measurement of NFkB subunit p65 in nuclear fractions of human brain lysates from control subjects (Ctrl) and AD patients (n Ctrl = 7 and n AD = 8, Student's t test).
(H) Western blotting of IkBa levels in Ctrl and AD human total protein lysates. Neuron-specific enolase (NSE) was used as a loading control.
(I) Quantification of the blots in (H) (Student's t test).
(J) C3 protein concentration in total protein lysates from control and AD brain samples (n Ctrl = 7 and n AD = 8, Student's t test). *p < 0.05; **p < 0.01; ***p < 0.001. See also Table S1 .
morphology and excitatory synaptic function through intraneuronal calcium dysregulation; and (4) antagonizing C3aR restores morphological and functional defects resulting from NFkB hyperactivation. Our studies therefore reveal a critical role for the astroglial IkBa/NFkB loop in neuronal homeostasis through a novel neuron-glia signaling pathway that has direct relevance for AD pathogenesis. Both NFkB and C3 are induced in astroglia by exposure to Ab and are upregulated in APP transgenic mice and human AD tissue. This pathway may also provide a potential entry point for therapeutic intervention because short-term C3aR inhibition produced nearly complete rescue of multiple cognitive deficits in APP transgenic mice.
NFkB/C3-Mediated Neuron-Glia Signaling in Neuronal Homeostasis
NFkB has been shown to regulate neuronal survival and function (Ahn et al., 2008; Kaltschmidt et al., 2006; Kassed et al., 2002; Levenson et al., 2004; Meffert et al., 2003) . These activities have been attributed, at least in part, to the presence of constitutive NFkB activity in neurons (Blondeau et al., 2001; Kaltschmidt et al., 1993 Kaltschmidt et al., , 1994 Kaltschmidt et al., , 1995 Kaltschmidt et al., , 2000 . However, recent studies by us and others reported that, compared with astroglia, neurons exhibit negligible NFkB activity (Lian et al., 2012; Mao et al., 2009) . Consistent with this assessment, we found that both IkBa and C3 are expressed at substantially higher levels in astroglia compared with neurons under both basal and TNF-a-stimulated conditions. Furthermore, only astroglial, but not neuronal, C3 is regulated in an NFkB-dependent manner. Therefore, although it remains possible that other IkBs may regulate neuronal NFkB, our results provide strong support for the hypothesis that IkBa is a critical mediator of NFkB activity in astroglia but not in neurons. Although this study is focused on addressing the pathological consequences of NFkB activation, the astroglial NFkB/C3-mediated neuron-glia interaction may also mediate neuronal and synaptic function under physiological conditions. For example, during early postnatal development, complement proteins, including C3 and C1q, are highly expressed in the brain (Stevens et al., 2007) , and C3aR has been reported to regulate the migration and differentiation of neuronal progenitor cells (Rahpeymai et al., 2006; Shinjyo et al., 2009) . Interestingly, NFkB is also transiently activated during neural development (Guerrini et al., 1997; Simakajornboon et al., 2001) , making it tempting to speculate that NFkB serves the same function in development as in the adult brain, and, in both cases, it indirectly controls neural function by regulating the onset and degree of complement activity in astroglia.
Previous studies have shown that glia-derived TNF-a controls neuronal synaptic strength (Beattie et al., 2002) and mediates synaptic scaling during activity blockade (Stellwagen and Malenka, 2006) . In this study, we found that TNF-a increases C3 mRNA expression and that enhanced astroglial NFkB/C3/ C3aR signaling promotes AMPAR membrane localization to increase synaptic strength. Taken together, these findings raise the possibility that C3/C3aR neuron-glia signaling may act downstream of TNF-a to promote synaptic plasticity.
In addition to astrocytes, NFkB and complement proteins are also abundantly expressed in microglia (Fä rber et al., 2009; Lucin and Wyss-Coray, 2009; Sheppard et al., 2011; Wyss-Coray and Rogers, 2012; Zhang et al., 2014) . Although we provide evidence for direct neuron-astroglia interaction, it is important to note that there may exist a parallel neuron-microglia interaction mediated through the same NFkB/complement pathway. Furthermore, astrocyte-derived complement proteins may also signal microglial activation, leading indirectly to neuronal dysfunction through a myriad of microglial-derived factors. Crosstalk between microglia, astroglia, and neurons has long confounded elucidation of their individual roles in neuroinflammatory damage. The combination of genetic and coculture approaches we used here to study neuron-astroglia interactions may provide a useful road map for future work on the neuron-microglia relationship.
NFkB/C3-Mediated Neuron-Glia Signaling in Alzheimer's Disease Activation of NFkB and complement are common features in AD and other neurological conditions. However, it has been difficult to establish whether NFkB and complement activation cause neuronal dysfunction or are a consequence of neuronal injury and neuroinflammation. In this study, we identified C3 as a bona fide astroglia-specific NFkB target that is both necessary and sufficient to produce neuronal impairment through C3aR and intraneuronal calcium signaling. Our data are consistent with the notion that calcium dysregulation is a major cause of defective synaptic function in multiple neurodegenerative diseases, AD in particular (LaFerla, 2002; Mattson, 2007) . Overall, we propose a model whereby Ab evokes astroglial NFkB activation and release of C3, which, through neuronal C3aR and intraneuronal calcium, increases synaptic excitation and disrupts dendritic morphology, the combination of which leads to network dysfunction. This model links Ab with synaptic defects and neuronal hyperexcitability through a novel neuron-glia signaling pathway and places the astroglial IkBa/NFkB regulatory loop and complement activation as integral events in AD pathogenesis.
C3aR Antagonists as Therapeutic Targets for AD Our findings that the astroglial NFkB/complement levels are inducible by Ab, that this pathway is elevated in AD mouse models and patient brain samples, and that inhibition of C3aR ameliorates the behavioral deficits in the AD mouse model support the notion that inhibiting this pathway may be therapeutically beneficial. This assessment is further supported by past studies documenting a general neuroprotective effect by blocking complement activation (Fonseca et al., 2009; Leinhase et al., 2006; Woodruff et al., 2008) . As a G protein-coupled receptor, C3aR may prove to be highly tractable for pharmaceutical inhibition, and, importantly, mice with complete C3aR deletion are overtly normal (Humbles et al., 2000) . Therefore, C3aR may make an attractive target for intervention in AD.
EXPERIMENTAL PROCEDURES Mouse Models and Manipulations
The mouse lines and behavioral protocols are described in the Supplemental Experimental Procedures.
Quantification of spine density was performed 3 weeks after bilateral stereotaxic injection of 1 ml AAV-GFP (Penn Vector Core, catalog no. AV-9-PV0101, 1 3 10 13 transduction unit (TU)/ml) into the mouse cortex (+2.0 mm anteriorposterior, ± 3.0 mm medial-lateral, À1.5 mm dorsal-ventral). Three days after stereotaxic injection, mice were injected intraperitoneally (i.p.) with 0.5% DMSO or C3aRA (1 mg/kg) three times per week (Mondays, Wednesdays, and Fridays) for 3 weeks. GcKO mice and controls at 9 or 15 months were used for behavioral testing and LTP recording. The APP/TTA mice and the TTA controls were tested at 8 months of age after 3 weeks of C3aRA or vehicle treatment.
All animal procedures were performed in accordance with NIH guidelines and with the approval of the Baylor College of Medicine Institutional Animal Care and Use Committee.
Primary Cell Culture, Neuron-Astroglia Coculture, Slice Culture, and Treatment Primary neurons were prepared from postnatal day 0 pups using a protocol described previously (Lian et al., 2012) . Primary astroglia were cultured using the same protocol but with astroglial medium (DMEM with 10% fetal bovine serum). Contaminating cells on top of the astroglia monolayer were removed by overnight shaking at 220 rpm at 37 C. For coculture, astroglial cells were seeded on Matrigel-coated cell culture inserts (Costar, catalog nos. 3450 and 3470) and transferred to day in vitro (DIV) 1 primary neurons. We supplemented 5 mM cytosine arabinoside to curb glia proliferation. Cocultures were maintained for 2 weeks before immunostaining or recording. Two independent cultures were used for all in vitro experiments. The NFkB inhibitor JSH23 (20 mM, Calbiochem, catalog no. 481408) and 50 ng/ml TNF-a (Sigma, catalog no. T0157) were added to astroglial cultures for 20 hr for the inhibitor assay. BAPTA/AM (Calbiochem, catalog no. 196419), C3 (Millipore, catalog no. 204885), C3aRA (Calbiochem, catalog no. SB290157), or C5aRA (Calbiochem, catalog no. W54011) at different dosages (specified in the figure legends) were added to cultures at DIV10 for long-term or at DIV14 for short-term incubation. AAV-GCaMP6s (Penn Vector Core, catalog no. AV-1-PV2824) were added to neuronal cultures at a multiplicity of infection of 2.41 3 10 6 immediately after neurons were seeded and removed when media was replaced. Synthetic Ab42 (Invitrogen, catalog no. 03-111) and rAb42 (Sigma, catalog no. SCP0048) peptides were prepared as described previously (Stine et al., 2003) and used at 100 nM on primary astroglia for 20 min before fixation for staining or for 20 hr before cell harvest for quantitative PCR (qPCR). Slice cultures were prepared following the protocol described in Gogolla et al. (2006) . One microliter AAV-GCaMP6s virus at a titer of 2.41 3 10 13 TU/ ml was added to the medium immediately before slices were plated and removed when the medium was replaced.
Quantitative RT-PCR and ELISA cDNA was synthesized and analyzed as described previously (Yang et al., 2009) . The primer sequences were as follows:
, and 5 0 -GATGCCTGCTTCACCACCTTCT-3 0 (GAPDH reverse). C3 levels in brain lysates were determined using a mouse C3 ELISA kit (Genway, catalog no. GWB-7555C7). Quantification of the relative nuclear p65 level was determined using a Cayman NFkB (p65) transcription factor assay kit (catalog no. 10007889).
Immunostaining and Image Processing and Quantification
Fixed primary neurons were washed, permeabilized, blocked, and incubated in primary antibody solution overnight at 4 C (mouse anti-MAP2, Millipore, catalog no. MAB3418, 1:2,000; rabbit anti-synaptophysin, Synaptic Systems, catalog no. 101 002, 1:2,000; mouse anti-GluR1, Millipore, catalog no. MAB2263, 1:500; rabbit anti-VGluT1, Synaptic Systems, catalog no. 135 302, 1:1,000; mouse anti-VGAT, Synaptic Systems, catalog no. 131 011, 1:1,000; mouse anti-GFAP, Millipore, catalog no. MAB3402, 1:2,000; and rabbit anti-p65, Cell Signaling Technology, catalog no. 8242, 1:100). For immunostaining of surface GluR1, neurons were incubated with diluted anti-GluR1 antibody (1:100) at 37 C for 5 min before fixation. Coverslips were mounted in DAPI solution after washing and secondary antibody incubation. Synapses were recognized as puncta positive for presynaptic markers (Syn, VGluT1, or VGAT) in proximity to the dendritic marker MAP2. NeuronJ (Meijering et al., 2004) and advanced Sholl analysis plug-ins of ImageJ were used to calculate total dendritic length and dendritic complexity. ImageJ was used to measure GluR1 fluorescent intensity over the whole cell surface, blots of surface GluR1, and synaptic density, which equal the number of positive puncta divided by the length of the dendrite. Adobe Photoshop was used to measure GluR1 expression in Syn + puncta using z stack images of both GluR1 and Syn channels. Spine density was calculated as the number of spines divided by dendritic length using the 3D renderings of AAV-GFP-infected neuronal dendritic spines reconstructed by Neurolucida (MBF Bioscience) (See Movie S1). Classification and quantification of the frequency and density of different spine types were performed using IMARIS software (Bitplane). AAV-GCaMP6s-infected neurons and slices were imaged using an EVOS fluorescence microscope (AMG) at 103 magnification. Images were processed by Adobe Photoshop to measure GFP fluorescence.
Electrophysiology
Hippocampal cultures were transferred to a recording chamber perfused with artificial cerebrospinal fluid (ACSF) solution containing 1 mM tetrodotoxin and 100 mM picrotoxin. mEPSCs were recorded using electrodes (borosilicate glass, WPI) filled with whole-cell solution with a resistance of 3-6 MU. Field recordings of Schaffer collateral LTP was performed as described previously (Peethumnongsin et al., 2010; Polito et al., 2014) . Stimulation of Schaffer collaterals from the CA3 region was performed with bipolar electrodes, whereas borosilicate glass capillary pipettes filled with recording ACSF (resistances of 2-3.5 MU) were used to record field excitatory postsynaptic potentials (fEPSPs) in the CA1 region.
Human Brain Tissues
Frozen frontal cortex brain tissues from control subjects and AD patients evaluated clinically and neuropathologically were obtained from the Oregon Brain Bank at Oregon Health and Science University. The demographic information of the samples is listed in Table S1 .
Statistics
All data are presented as mean ± SEM. Pairwise comparisons were analyzed using a two-tailed Student's t test, whereas a one-way, two-way, or three-way ANOVA followed by Bonferroni post hoc analysis, pairwise comparison, or planned means comparison was used for multiple comparisons. p values of less than or equal to 0.05, 0.01, and 0.001 were considered statistically significant. p values of higher than 0.05 were considered nonsignificant (NS).
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